RIF1 and prostate carcinoma: Analysis of alternatively spliced transcripts in patient-matched normal and cancer samples revealed a shift towards exclusion of RIF1 Exon 31 and expression of the RIF1-S splice variant in several cancers (Figure 1F), including breast, colon, lung, liver, and prostate cancer.